Podcast - The Future of Healthcare: Interview with Dr Nicholas Moore

Ahead of the Curves - Post-Covid what does the future of healthcare look like?

Nick Moore is the Managing Director, Biopharma, Healthcare, Stifel and has more than 20 years’ experience in the Healthcare industry. He trained originally as a medical doctor at Cambridge University and Harvard Medical School.  In December 2013, Nicholas was named as one of the Top 40 Under 40 Rising Stars in Investment Banking by Financial News, partly in recognition of the more than 20 equity capital markets transactions he completed in 2013 alone. Since mid-2013, Nicholas has focused on raising equity capital for European healthcare companies, especially those companies in the biopharma subsector targeting investment from U.S.-based healthcare specialist investors.

In this wide-ranging podcast interview he talks about the effects of the covid pandemic, how you learn to back winners within healthcare, the profound changes coming down the line in the practice of medicine and the gulf between research and getting new treatments to the patient.

Matthew Gwyther

Matthew edited Management Today for 17 years and during that time won the coveted  BSME Business Magazine Editor of the year on a record five occasions. During a fifteen year career as a freelance he wrote for the Sunday Times magazine, The Independent, The Telegraph, The Observer, GQ and was a contributing editor to Business magazine. He was PPA Business Feature Writer of the Year in 2001. He has also worked on two drama serials one for Channel 4 and one for the BBC.  Before becoming a journalist he had a brief and inauspicious spell as a civil servant working at the Medical Research Council in its London Secretariat.

Matthew is the main presenter on BBC Radio 4’s In Business programme.

Matthew is also the co-author of Exposure published by Penguin in London and New York in the Autumn of 2012. It is the story of whistleblower Michael Woodford, the “Southend samurai” who left school at 16 and worked his way up to the top post of the Japanese industrial conglomerate Olympus, only to discover that his board were involved in a two billion dollar fraud.

Contact: matthew.gwyther@jerichochambers.com

https://www.linkedin.com/in/matthew-gwyther-8b043210/
Previous
Previous

Tax and ESG - the view of ESG experts

Next
Next

Global Responsible Tax: December 2021 Newsletter